Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil

Hemoglobinopathies are hereditary disorders of the hemoglobin molecule with a high prevalence worldwide. Brazil has a prevalence of 0.1 to 0.3% of newborns with sickle cell anemia and 20.0 to 25.0% of heterozygous alpha2 thalassemia among African Brazilians. In the present study, we investigated the...

ver descrição completa

Detalhes bibliográficos
Autores: Adorno, Elisângela Vitória, Couto, Fábio David, Moura Neto, José Pereira de, Menezes, Joelma Figueiredo, Rêgo, Marco, Reis, Mitermayer Galvão dos, Gonçalves, Marilda Souza
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2005
País:Brasil
Recursos:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Cadernos de Saúde Pública
Idioma:inglés
OAI Identifier:oai:ojs.teste-cadernos.ensp.fiocruz.br:article/2571
Acesso em linha:https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2571
Access Level:acceso abierto
Palavra-chave:Hemoglobinopathies
Sickle Cell Anemia
Thalassemia
Newborn Infant
Descrição
Resumo:Hemoglobinopathies are hereditary disorders of the hemoglobin molecule with a high prevalence worldwide. Brazil has a prevalence of 0.1 to 0.3% of newborns with sickle cell anemia and 20.0 to 25.0% of heterozygous alpha2 thalassemia among African Brazilians. In the present study, we investigated the presence of variant hemoglobins and alpha2(3.7 Kb) and alpha2(4.2 Kb) thalassemia in newborns from Salvador, Bahia, Brazil. Samples of umbilical cord blood from a total of 590 newborns were analyzed, of which 57 (9.8%) were FAS; 36 (6.5%) FAC; one (0.2%) SF; and five (0.9%) FSC. One hundred fourteen (22.2%) newborns had alpha2(3.7 Kb) thalassemia, of whom 101 (19.7%) were heterozygous and 13 (2.5%) homozygous, showing statistical significance for hematological data between newborns with normal alpha genes and alpha2(3.7 Kb) thalassemia carriers. The alpha2(4.2 Kb) thalassemia was not found. Frequencies found in the present study confirm that hemoglobinopathies are a public health problem in Brazil, emphasizing the need for neonatal screening and genetic counseling programs.